These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: a case control study. Lundqvist K; Broomé U Dis Colon Rectum; 1997 Apr; 40(4):451-6. PubMed ID: 9106695 [TBL] [Abstract][Full Text] [Related]
24. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Soetikno RM; Lin OS; Heidenreich PA; Young HS; Blackstone MO Gastrointest Endosc; 2002 Jul; 56(1):48-54. PubMed ID: 12085034 [TBL] [Abstract][Full Text] [Related]
25. Synchronic signet ring carcinoma and adenocarcinoma complicating extensive and long-standing ulcerative colitis. Pontes J; Fernandes C; Panao E; Castro L; Vicente L; Neto M; Campos M; Pontes F Hepatogastroenterology; 1999; 46(25):236-9. PubMed ID: 10228799 [TBL] [Abstract][Full Text] [Related]
26. Splenic Tumor in a Patient After Liver Transplantation. Stadnik A; Wójcicki M; Milkiewicz P Gastroenterology; 2022 Feb; 162(2):e14-e15. PubMed ID: 34147521 [No Abstract] [Full Text] [Related]
27. Nephrotic syndrome from 5-ASA for ulcerative colitis? Complicated by carcinoma of the colon and sclerosing cholangitis. Fornaciari G; Maccari S; Borgatti PP; Rustichelli R; Amelio N; Lattuada I; Plancher AC J Clin Gastroenterol; 1997 Jan; 24(1):37-9. PubMed ID: 9013349 [TBL] [Abstract][Full Text] [Related]
28. Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis? Marelli L; Xirouchakis E; Kalambokis G; Cholongitas E; Hamilton MI; Burroughs AK Gut; 2011 Sep; 60(9):1224-8. PubMed ID: 21402617 [TBL] [Abstract][Full Text] [Related]
29. Onerous concomitant complications of ulcerative colitis: a case report. Yüksel O; Arhan M; Köklü S; Oğuz P; Parlak E Z Gastroenterol; 2007 May; 45(5):379-81. PubMed ID: 17503316 [TBL] [Abstract][Full Text] [Related]
30. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation. Loftus EV; Aguilar HI; Sandborn WJ; Tremaine WJ; Krom RA; Zinsmeister AR; Graziadei IW; Wiesner RH Hepatology; 1998 Mar; 27(3):685-90. PubMed ID: 9500695 [TBL] [Abstract][Full Text] [Related]
31. The fate of indefinite and low-grade dysplasia in ulcerative colitis and primary sclerosing cholangitis colitis before and after liver transplantation. Eaton JE; Smyrk TC; Imam M; Pardi DS; Loftus EV; Owens VL; Talwalkar JA Aliment Pharmacol Ther; 2013 Oct; 38(8):977-87. PubMed ID: 24033551 [TBL] [Abstract][Full Text] [Related]
32. Adenocarcinoma of the cecum as the first manifestation of ulcerative colitis complicated by primary sclerosing cholangitis and endomyocardial fibrosis. Magro F; Correia M; Moreira G; Dinis-Ribeiro M; Amandio V; Carneiro F; Ribeiro T Inflamm Bowel Dis; 2002 Jul; 8(4):287-90. PubMed ID: 12131613 [TBL] [Abstract][Full Text] [Related]
33. Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis. Papatheodoridis GV; Hamilton M; Mistry PK; Davidson B; Rolles K; Burroughs AK Gut; 1998 Nov; 43(5):639-44. PubMed ID: 9824344 [TBL] [Abstract][Full Text] [Related]
34. Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis. Broomé U; Löfberg R; Lundqvist K; Veress B Dis Colon Rectum; 1995 Dec; 38(12):1301-5. PubMed ID: 7497843 [TBL] [Abstract][Full Text] [Related]
35. Farnesoid X receptor expression is decreased in colonic mucosa of patients with primary sclerosing cholangitis and colitis-associated neoplasia. Torres J; Bao X; Iuga AC; Chen A; Harpaz N; Ullman T; Cohen BL; Pineton de Chambrun G; Asciutti S; Odin JA; Sachar DB; Gaskins HR; Setchell K; Colombel JF; Itzkowitz SH Inflamm Bowel Dis; 2013 Feb; 19(2):275-82. PubMed ID: 23348121 [TBL] [Abstract][Full Text] [Related]
36. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis. Marchesa P; Lashner BA; Lavery IC; Milsom J; Hull TL; Strong SA; Church JM; Navarro G; Fazio VW Am J Gastroenterol; 1997 Aug; 92(8):1285-8. PubMed ID: 9260790 [TBL] [Abstract][Full Text] [Related]
38. Effectiveness of Ursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis with Ulcerative Colitis: A Pediatric Case. Fujita Y; Sugaya T; Inui A; Yoshihara S Tohoku J Exp Med; 2021 Feb; 253(2):109-112. PubMed ID: 33551380 [TBL] [Abstract][Full Text] [Related]
39. Primary sclerosing cholangitis in ulcerative colitis--a risk factor for the development of dysplasia and DNA aneuploidy? Broomé U; Lindberg G; Löfberg R Gastroenterology; 1992 Jun; 102(6):1877-80. PubMed ID: 1587406 [TBL] [Abstract][Full Text] [Related]
40. Associated ulcerative colitis, sclerosing cholangitis, and insulin-dependent diabetes mellitus. Kay M; Wyllie R; Michener W; Caulfield M; Steffen R Cleve Clin J Med; 1993; 60(6):473-8. PubMed ID: 8287509 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]